FDAnews
www.fdanews.com/articles/172651-cadence-biomedical-research-collaborators-secure-grant-to-study-effects-of-neurorehabilitation-device

Cadence Biomedical Collaborators Secure Grant for Neurorehabilitation Device

August 17, 2015

Neurorehabilitation device manufacturer Cadence Biomedical announced that its research collaborators from the Université de Montréal and the Center for Interdisciplinary Research in Rehabilitation of Greater Montreal have secured a grant from the Physiotherapy Foundation of Canada and the Quebec Rehabilitation Research Network.

The grant will fund the study of the effects of Candence’s product Kickstart, a device designed to restore walking ability from neurological conditions, on stroke survivors.

Dr. Dany Gagnon of the Université de Montréal is the principal investigator on the grant, while Cadence COO Brian Glaister will serve as a co-investigator.

Headquartered in Seattle, Wash., Cadence is a medical device company that focuses on helping people with neurological impairments be retrained to walk. — Michael Cipriano